Victoza (liraglutide)
Direct answer
What you need to know
Evidence strength: StrongVictoza is liraglutide, a GLP-1 receptor agonist approved for type 2 diabetes and given as a daily injection. Liraglutide for type 2 diabetes, taken once daily rather than weekly. Daily dosing is the main practical reason the weekly products displaced it.
Key takeaways
- Molecule: liraglutide. Approved for: type 2 diabetes.
- Form: daily injection. Prescription-only, like every product in this class.
- Same molecule as Saxenda, approved for a different use.
Important limitation: This page does not reproduce Victoza’s label. Side-effect rates, contraindications, dosing schedules and interactions belong to the prescribing information, and we link to the class-wide guides rather than paraphrasing a label.
Next action: The label for Victoza is published on DailyMed and is the authority on how it is taken. Separately, here is how Victoza is priced on each route.
Primary sources: DailyMed, U.S. National Library of Medicine, U.S. Food & Drug Administration
General education, not medical advice. This page does not publish dosing instructions.
At a glance
- Molecule
- liraglutide
- Approved for
- type 2 diabetes
- Form
- daily injection
- Self-pay, direct from manufacturer
- Not published
- Prescription required
- Yes — as for every GLP-1 receptor agonist
Like Trulicity, its label carries a cardiovascular risk-reduction indication alongside glycemic control.
The confusion worth clearing up
Victoza and Saxenda are the same molecule at different doses with different approved uses — diabetes and weight management respectively. It is exactly the Ozempic and Wegovy arrangement, one drug generation earlier, and it confuses people for the same reason.
The class, the molecule and the brand name are three different levels, and most “versus” questions in this category dissolve once they are separated — which level of that Victoza belongs to, and what it is being compared against is the thing worth settling first.
What this page deliberately leaves out
Side-effect rates, contraindications, dosing schedules, and drug interactions for Victoza are on its FDA-approved label, published on DailyMed. We are not going to reproduce them here from anywhere else, because a drug page that looks complete but was assembled second-hand is more dangerous than one that is visibly partial.
What we do cover, at the level of the class rather than the product:
- Side effects — what is common, what is serious, and the boxed warning.
- Dosing and titration — why doses start low and climb, and what happens at each step.
- How these medications work — the four mechanisms, and why they also explain the side effects.
Questions people ask about Victoza
Is Victoza a GLP-1?
Yes. Victoza is liraglutide, a GLP-1 receptor agonist, approved for type 2 diabetes and given as a daily injection. "GLP-1" is the drug class; liraglutide is the molecule; Victoza is the brand name that molecule is sold under for this use.
Is Victoza the same as Saxenda?
They are the same molecule — liraglutide — approved for different uses. Victoza is approved for type 2 diabetes; Saxenda for chronic weight management. That difference is not pharmacological, but it decides how an insurer treats each one, which is usually the practical question hiding inside "which is better".
Do you need a prescription for Victoza?
Yes, in the United States, as for every GLP-1 receptor agonist. Anything sold as Victoza without a prescription is not Victoza, whatever the label says — and a product bought outside the prescribing chain carries none of the manufacturing verification the approved product does.
How much does Victoza cost?
The manufacturer does not publish a self-pay price for Victoza. Where a price is not published we say so rather than estimate one, so the total for this product depends on the route you take to it.
Before you act on anything here
- Victoza is prescription-only. Anything sold as Victoza without a prescription is not Victoza.
- Take dosing and administration from the label on your own prescription, not from this page or any other.
- Approval status and price are checked on the dates shown and both change — re-verify before relying on either.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: The approved indication and dosage form for Victoza, and the labelled information this page deliberately does not reproduce.
- Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: Approval status for Victoza, checkable in Drugs@FDA and the Orange Book.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.